Tonix Pharmaceuticals stock halted ahead of FDA approval news
HOUSTON - KBR (NYSE:KBR), a $6.5 billion market cap company with $704 million in EBITDA, has secured a $2.459 billion NASA contract to support astronaut health, occupational health, and research aimed at mitigating health risks for future space missions, the company announced Wednesday. According to InvestingPro analysis, KBR is currently trading below its Fair Value.
The five-year contract begins November 1 and includes two possible option periods that could extend it through 2035, potentially increasing the total value to $3.6 billion. The majority of the work will be performed at NASA’s Johnson Space Center in Houston. For deeper insights into KBR’s financial health and growth potential, including 8 additional ProTips, check out the comprehensive Pro Research Report available on InvestingPro.
Under the Human Health and Performance Contract 2, KBR will provide support services for several NASA programs including the Human Research Program, International Space Station Program, Commercial Crew Program, and the Artemis campaign. The company’s responsibilities include ensuring crew health, safety, and performance; providing occupational health services; and conducting research to mitigate risks for future spaceflight crews.
"This contract reinforces KBR’s leadership in human spaceflight operations and highlights our expertise in supporting NASA’s vision for space exploration," said Mark Kavanaugh, KBR President of Defense, Intel and Space, according to the press release.
The contract represents a follow-on to KBR’s existing work with NASA, building on the company’s long-standing role in human spaceflight operations. KBR employs approximately 37,000 people worldwide and operates in over 29 countries.
This award continues KBR’s involvement in NASA’s space exploration initiatives, with the company having supported human spaceflight for more than 60 years. The company has demonstrated strong financial performance with 12.31% revenue growth in the last twelve months and maintains a favorable PEG ratio of 0.19, indicating attractive valuation relative to growth. Discover more detailed analysis and metrics with a subscription to InvestingPro.
In other recent news, KBR Inc. reported its second-quarter earnings for 2025, showing an earnings per share (EPS) of $0.91, which slightly exceeded expectations of $0.90. However, the company’s revenue came in at $1.95 billion, falling short of the anticipated $2.09 billion. Additionally, KBR has been downgraded by BofA Securities from Buy to Neutral, with a lowered price target of $55.00 from $70.00. This downgrade followed the Department of Defense’s cancellation of a $20 billion HomeSafe contract, which had been expected to contribute to KBR’s medium-term growth.
In other developments, KBR has secured a contract to provide front-end engineering design for the Abadi LNG project in Indonesia, a project of national strategic importance. KBR and Axiom Space also completed successful underwater tests of a next-generation spacesuit at NASA’s Neutral Buoyancy Laboratory. Furthermore, KBR announced the appointment of former Shell executive Huibert H. Vigeveno to its board of directors, effective August 5, 2025. These recent developments reflect KBR’s ongoing efforts in various sectors despite recent challenges.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.